-0.18 | -0.43%
| Price and Volume | |
|---|---|
| Recent Price | 41.83 |
| 52 Week High | 53.27 |
| 52 Week Low | 35.30 |
| Avg. Daily Vol. (Mil) | 1.37 |
| Beta (3 year) | 0.96 |
| Share Related Items | |
| Mkt Cap (Mil) | 7,469.87 |
| Shares Out (Mil) | 178.58 |
| Float (Mil) | 177.57 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.80 |
| Current Ratio | 1.40 |
| LT Debt/ Equity | 0.45 |
| Total Debt / Equity | 0.54 |
| Valuation Ratios | |
| Price Earnings | 18.40 |
| Price/Sales | 1.96 |
| Price/Book | 1.59 |
| Price/Cash Flow | 8.70 |
| Per Share Data | |
| Earnings | 2.27 |
| Sales | 21.39 |
| Book Value | 26.34 |
| Cash Flow | 4.80 |
| Business Summary | |
|---|---|
| Life Technologies Corp is a global biotechnology tools company, which delivers a range of products and services including systems, instruments, reagents and custom services. | |
| General Information | |
| 5791 Van Allen Way
Carlsbad, CA 92008 |
|
| www.invitrogen.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 10400 | |
| CEO: Gregory T. Lucier | |
| Short Interest | |
| Current Month (Mil) | 7.14 |
| Previous Month (Mil) | 6.60 |
| Short Interest Ratio (Days) | 5.40 |
| Management Effectiveness | |
| Return on Equity | 8.90 |
| Return on Assets | 4.90 |
| Return on Investments | 6.10 |
| Profitability | |
| Gross Margin | 67.70 |
| EBIT Margin | 17.70 |
| Profit Margin | 10.90 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,454.83 | 1,317.82 | 2,837.53 | 17.45 |
Oil *
107.26
|
|
DOWN
74.92 |
DOWN
2.86 |
DOWN
1.85 |
DOWN
0.14 |
10 Yr
1.74%
SPDR Gold
152.68
|
|
-0.60%
|
-0.22%
|
-0.07%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet